RESUMEN
INTRODUCTION: To date, most risk stratification studies in long-QT syndrome (LQTS) have focused on identification of high-risk subjects. Current data on the long-term clinical course of low-risk adult LQTS patients are limited. METHODS AND RESULTS: Patients in this study were from the Rochester-based LQTS Registry. We hypothesized that long-term survival of LQT1-2 patients with QTc <500 milliseconds and no cardiac symptoms before age 20 (n = 523) would be similar to that of their unaffected genotype-negative family members (n = 1,134). Kaplan-Meier survival analysis and multivariate Cox proportional hazards regression models were used to evaluate the incidence and risk of all-cause mortality in the study population. The low-risk LQTS study group comprised 27% (523/1,919) of genetically confirmed LQTS Registry patients alive at age 20. The cumulative probability of all-cause mortality between age 20 and 65 was similar in the low-risk LQTS group and the genotype-negative control group (4.3% and 4.4%, respectively at age 65; P = 0.49 for overall difference). Multivariate analysis showed no significant difference in the risk of all-cause mortality between the 2 groups (HR = 0.89; 95% CI 0.33-2.43, P = 0.82). Consistent results were revealed in subgroup analyses in female and male LQTS patients and in patients with genetically identified LQT1 and LQT2 mutations. CONCLUSIONS: We identified a sizeable proportion of low-risk, adult LQTS patients with no cardiac symptoms before age 20 and QTc<500 milliseconds who had 45-year survival similar to unaffected family members.
Asunto(s)
Análisis Mutacional de ADN , Pruebas Genéticas/métodos , Sistema de Conducción Cardíaco/fisiopatología , Canal de Potasio KCNQ1/genética , Canal de Potasio KCNQ2/genética , Mutación , Síndrome de Romano-Ward/diagnóstico , Síndrome de Romano-Ward/genética , Potenciales de Acción , Adulto , Anciano , Enfermedades Asintomáticas , Distribución de Chi-Cuadrado , Femenino , Marcadores Genéticos , Predisposición Genética a la Enfermedad , Frecuencia Cardíaca , Humanos , Incidencia , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Análisis Multivariante , New York , Fenotipo , Valor Predictivo de las Pruebas , Modelos de Riesgos Proporcionales , Sistema de Registros , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Síndrome de Romano-Ward/mortalidad , Síndrome de Romano-Ward/fisiopatología , Factores de Tiempo , Adulto JovenRESUMEN
BACKGROUND: Women with congenital long-QT syndrome experience an increased risk for cardiac events after the onset of adolescence that is more pronounced among carriers of the LQT2 genotype. We hypothesized that the hormonal changes associated with menopause may affect clinical risk in this population. METHODS AND RESULTS: We used a repeated-events analysis to evaluate the risk for recurrent syncope during the menopause transition and postmenopausal periods (5 years before and after the age at onset of menopause, respectively) among 282 LQT1 (n=151) and LQT2 (n=131) women enrolled in the Long-QT Syndrome Registry. Multivariate analysis showed that the risk for recurrent syncope (n=150) among LQT2 women was significantly increased during both menopause transition (hazard ratio, 3.38; P=0.005) and the postmenopausal period (hazard ratio, 8.10; P<0.001) compared with the reproductive period. The risk increase was evident among women who did or did not receive estrogen therapy. In contrast, among LQT1 women, the onset of menopause was associated with a reduction in the risk for recurrent syncope (hazard ratio, 0.19; P=0.05; P=0.02 for genotype-by-menopause interaction). Only 22 women (8%) experienced aborted cardiac arrest or sudden cardiac death during follow-up. The frequency of aborted cardiac arrest/sudden cardiac death showed a similar genotype-specific association with the onset of menopause. CONCLUSIONS: The onset of menopause is associated with a significant increase in the risk of cardiac events (dominated by recurrent episodes of syncope) in LQT2 women, suggesting that careful follow-up and continued long-term therapy are warranted in this population.
Asunto(s)
Muerte Súbita Cardíaca/epidemiología , Síndrome de Jervell-Lange Nielsen/mortalidad , Menopausia , Síndrome de Romano-Ward/mortalidad , Adulto , Distribución por Edad , Canal de Potasio ERG1 , Terapia de Reemplazo de Estrógeno/estadística & datos numéricos , Canales de Potasio Éter-A-Go-Go/genética , Femenino , Estudios de Seguimiento , Genotipo , Humanos , Síndrome de Jervell-Lange Nielsen/genética , Canal de Potasio KCNQ1/genética , Persona de Mediana Edad , Recurrencia , Factores de Riesgo , Síndrome de Romano-Ward/genética , Síncope/genética , Síncope/mortalidadRESUMEN
INTRODUCTION: Sudden unexplained death account for one-third of all sudden natural deaths in the young (1-35 years). Hitherto, the prevalence of genopositive cases has primarily been based on deceased persons referred for postmortem genetic testing. These deaths potentially may represent the worst of cases, thus possibly overestimating the prevalence of potentially disease causing mutations in the 3 major long-QT syndrome (LQTS) genes in the general population. We therefore wanted to investigate the prevalence of mutations in an unselected population of sudden unexplained deaths in a nationwide setting. METHODS: DNA for genetic testing was available for 44 cases of sudden unexplained death in Denmark in the period 2000-2006 (equaling 33% of all cases of sudden unexplained death in the age group). KCNQ1, KCNH2, and SCN5A were sequenced and in vitro electrophysiological studies were performed on novel mutations. RESULTS: In total, 5 of 44 cases (11%) carried a mutation in 1 of the 3 genes corresponding to 11% of all investigated cases (R190W KCNQ1, F29L KCNH2 (2 cases), P297S KCNH2 and P1177L SCN5A). P1177L SCN5A has not been reported before. In vitro electrophysiological studies of P1177L SCN5A revealed an increased sustained current suggesting a LQTS phenotype. CONCLUSION: In a nationwide setting, the genetic investigation of an unselected population of sudden unexplained death cases aged 1-35 years finds a lower than expected number of mutations compared to referred populations previously reported. We therefore conclude that the prevalence of mutations in the 3 major LQTS associated genes may not be as abundant as previously estimated.
Asunto(s)
Muerte Súbita Cardíaca/etiología , Canales de Potasio Éter-A-Go-Go/genética , Canal de Potasio KCNQ1/genética , Síndrome de QT Prolongado/genética , Mutación , Canal de Sodio Activado por Voltaje NAV1.5/genética , Adolescente , Adulto , Factores de Edad , Análisis de Varianza , Autopsia , Niño , Preescolar , Estudios de Cohortes , Análisis Mutacional de ADN , Muerte Súbita Cardíaca/epidemiología , Dinamarca , Canal de Potasio ERG1 , Técnicas Electrofisiológicas Cardíacas , Canales de Potasio Éter-A-Go-Go/metabolismo , Femenino , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Células HEK293 , Humanos , Lactante , Canal de Potasio KCNQ1/metabolismo , Síndrome de QT Prolongado/metabolismo , Síndrome de QT Prolongado/mortalidad , Masculino , Potenciales de la Membrana , Canal de Sodio Activado por Voltaje NAV1.5/metabolismo , Técnicas de Placa-Clamp , Linaje , Fenotipo , Síndrome de Romano-Ward/genética , Síndrome de Romano-Ward/mortalidad , Transfección , Adulto JovenRESUMEN
BACKGROUND: Beta-blocker efficacy in long-QT syndrome type 1 is good but variably reported, and the causes of cardiac events despite beta-blocker therapy have not been ascertained. METHODS AND RESULTS: This was a retrospective study of the details surrounding cardiac events in 216 genotyped long-QT syndrome type 1 patients treated with beta-blocker and followed up for a median time of 10 years. Before beta-blocker, cardiac events occurred in 157 patients (73%) at a median age of 9 years, with cardiac arrest (CA) in 26 (12%). QT-prolonging drugs were used by 17 patients; 9 of 17 (53%) had CA compared with 17 of 199 nonusers (8.5%; odds ratio, 12.0; 95% confidence interval, 4.1 to 35.3; P<0.001). After beta-blocker, 75% were asymptomatic, and cardiac events were significantly reduced (P<0.001), with a median event count (quartile 1 to 3) per person of 0 (0 to 1). Twelve patients (5.5%) suffered CA/sudden death, but 11 of 12 (92%) were noncompliant (n=8), were on a QT-prolonging drug (n=2), or both (n=1) at the time of the event. The risk for CA/sudden death in compliant patients not taking QT-prolonging drugs was dramatically less compared with noncompliant patients on QT-prolonging drugs (odds ratio, 0.03; 95% confidence interval, 0.003 to 0.22; P=0.001). None of the 26 patients with CA before beta-blocker had CA/sudden death on beta-blockers. CONCLUSIONS: beta-Blockers are extremely effective in long-QT syndrome type 1 and should be administered at diagnosis and ideally before the preteen years. beta-Blocker noncompliance and use of QT-prolonging drug are responsible for almost all life-threatening "beta-blocker failures." beta-Blockers are appropriate therapy for asymptomatic patients and those who have never had a CA or beta-blocker therapy. Routine implantation of cardiac defibrillators in such patients does not appear justified.
Asunto(s)
Antagonistas Adrenérgicos beta/uso terapéutico , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Cooperación del Paciente , Síndrome de Romano-Ward/tratamiento farmacológico , Adolescente , Antagonistas Adrenérgicos beta/farmacocinética , Adulto , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Mutación/genética , Preparaciones Farmacéuticas/metabolismo , Estudios Retrospectivos , Síndrome de Romano-Ward/genética , Síndrome de Romano-Ward/mortalidad , Insuficiencia del Tratamiento , Adulto JovenRESUMEN
BACKGROUND: Type-1 long-QT syndrome (LQTS) is caused by loss-of-function mutations in the KCNQ1-encoded I(Ks) cardiac potassium channel. We evaluated the effect of location, coding type, and biophysical function of KCNQ1 mutations on the clinical phenotype of this disorder. METHODS AND RESULTS: We investigated the clinical course in 600 patients with 77 different KCNQ1 mutations in 101 proband-identified families derived from the US portion of the International LQTS Registry (n=425), the Netherlands' LQTS Registry (n=93), and the Japanese LQTS Registry (n=82). The Cox proportional hazards survivorship model was used to evaluate the independent contribution of clinical and genetic factors to the first occurrence of time-dependent cardiac events from birth through age 40 years. The clinical characteristics, distribution of mutations, and overall outcome event rates were similar in patients enrolled from the 3 geographic regions. Biophysical function of the mutations was categorized according to dominant-negative (> 50%) or haploinsufficiency (< or = 50%) reduction in cardiac repolarizing I(Ks) potassium channel current. Patients with transmembrane versus C-terminus mutations (hazard ratio, 2.06; P<0.001) and those with mutations having dominant-negative versus haploinsufficiency ion channel effects (hazard ratio, 2.26; P<0.001) were at increased risk for cardiac events, and these genetic risks were independent of traditional clinical risk factors. CONCLUSIONS: This genotype-phenotype study indicates that in type-1 LQTS, mutations located in the transmembrane portion of the ion channel protein and the degree of ion channel dysfunction caused by the mutations are important independent risk factors influencing the clinical course of this disorder.
Asunto(s)
Canal de Potasio KCNQ1/genética , Mutación , Síndrome de Romano-Ward/genética , Adolescente , Antagonistas Adrenérgicos beta/uso terapéutico , Adulto , Niño , Preescolar , Codón sin Sentido , Muerte Súbita Cardíaca/epidemiología , Muerte Súbita Cardíaca/prevención & control , Femenino , Mutación del Sistema de Lectura , Predisposición Genética a la Enfermedad , Genotipo , Paro Cardíaco/epidemiología , Humanos , Lactante , Recién Nacido , Transporte Iónico/genética , Japón/epidemiología , Canal de Potasio KCNQ1/química , Canal de Potasio KCNQ1/fisiología , Estimación de Kaplan-Meier , Masculino , Potenciales de la Membrana , Modelos Moleculares , Mutagénesis Insercional , Mutación Missense , Países Bajos/epidemiología , Fenotipo , Potasio/metabolismo , Modelos de Riesgos Proporcionales , Estructura Terciaria de Proteína , Transporte de Proteínas , Sitios de Empalme de ARN/genética , Sistema de Registros , Factores de Riesgo , Síndrome de Romano-Ward/complicaciones , Síndrome de Romano-Ward/tratamiento farmacológico , Síndrome de Romano-Ward/mortalidad , Eliminación de Secuencia , Síncope/epidemiología , Estados Unidos/epidemiologíaRESUMEN
BACKGROUND: A 10% cumulative incidence and a 0.3% per year incidence rate of sudden cardiac death in patients younger than 40 years and without therapy have been reported in type 1 long-QT syndrome. The Y111C-KCNQ1 mutation causes a severe phenotype in vitro, suggesting a high-risk mutation. This study investigated the phenotype among Y111C-KCNQ1 mutation carriers in the Swedish population with a focus on life-threatening cardiac events. METHODS AND RESULTS: We identified 80 mutation carriers in 15 index families, segregating the Y111C-KCNQ1 mutation during a national inventory of mutations causing the long-QT syndrome. Twenty-four mutation carriers <40 years experienced syncope (30%). One mutation carrier had an aborted cardiac arrest (1.25%). No case of sudden cardiac death was reported during a mean nonmedicated follow-up of 25+/-20 years. This corresponds to a low incidence rate of life-threatening cardiac events (0.05%/year versus 0.3%/year, P=0.025). In 8 Y111C families connected by a common ancestor, the natural history of the mutation was assessed by investigating the survival over the age of 40 years for 107 nonmedicated ascertained mutation carriers (n=24) and family members (n=83) born between 1873 and 1968. In total, 4 deaths in individuals younger than 40 years were noted: 1 case of noncardiac death and 3 infant deaths between 1873 and 1915. CONCLUSIONS: The dominant-negative Y111C-KCNQ1 mutation, associated with a severe phenotype in vitro, presents with a low incidence of life-threatening cardiac events in a Swedish population. This finding of discrepancy emphasizes the importance of clinical observations in the risk stratification of long-QT syndrome.